Clinical Trials
4
Active:3
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Financial Toxicity and Patient-Reported Outcomes in GEP-NEN During Treatment
Recruiting
- Conditions
- Neuroendocrine Tumors
- First Posted Date
- 2022-04-19
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Massimo Falconi
- Target Recruit Count
- 400
- Registration Number
- NCT05334290
- Locations
- 🇮🇹
IRCCS Ospedale San Raffaele, Milan, Italy
Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes
Active, not recruiting
- Conditions
- Nutritional StatusPancreatic CancerPatient Reported Outcome MeasuresRecovery of FunctionQuality of LifePancreatectomy
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Massimo Falconi
- Target Recruit Count
- 560
- Registration Number
- NCT04431076
- Locations
- 🇮🇹
IRCCS San Raffaele, Milano, Italy
Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study
Active, not recruiting
- Conditions
- Overall SurvivalPancreatic CancerDisease Free Survival
- First Posted Date
- 2020-01-29
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Massimo Falconi
- Target Recruit Count
- 800
- Registration Number
- NCT04245644
- Locations
- 🇮🇹
IRCCS San Raffaele, Milan, Italy
A New Scoring System for Perineural and Vascular Invasion in Pancreatic Cancer
Active, not recruiting
- Conditions
- Pancreas Cancer
- First Posted Date
- 2019-07-18
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Massimo Falconi
- Target Recruit Count
- 500
- Registration Number
- NCT04024358
- Locations
- 🇮🇹
IRCCS San Raffaele, Milan, Italy
News
No news found